Financial News
Bluebird Bio shares pop on what CEO calls ‘very exciting’ cancer news
June 05, 2017 at 17:28 PM EDT
Bluebird Bio CEO Nick Leschly said the multiple myeloma patients in a study have had an "incredible response rate."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
